New biotech statistical framework to be established by 2028

Deputy Prime Minister Nguyen Chi Dung has signed Prime Ministerial Decision No. 208/QD-TTg, approving a scheme for the statistical assessment of biotechnology’s contribution to socio-economic development (hereafter referred to as the Scheme).

The Scheme aims to develop a set of indicators and statistical methodologies for biotechnology, organize data collection, and operate a stable statistical system. This framework will ensure that the proportional contribution of biotechnology to socio-economic development is identified and monitored periodically, providing a basis for evaluating development goals and the application of biotechnology.

According to the roadmap, in 2026, the focus will be placed on researching international methodologies and experiences regarding the statistical assessment of biotechnology's contribution. This phase includes creating a directory of economic activities that reflect the scope and scale of biotechnology applications.

In 2027, authorities will develop specific indicators and survey plans, conduct pilot surveys, and collect data on biotechnology's contribution across several economic sectors. These efforts will serve as the basis for standardizing the final indicator set and survey methods.

By 2028, the official set of indicators and statistical methodologies for measuring biotechnology’s contribution to socio-economic development will be formally issued. From 2029 onwards, periodic nationwide surveys will be conducted to collect data and measure the sector’s impact.

From 2030, the system of biotechnology statistical indicators will continue to be refined to ensure the consistent monitoring of the sector's contribution across all fields of the economy. This data will serve as a foundation for evaluation and policy direction to achieve the biotechnology development and application goals for 2045, as set out in the Politburo’s Resolution No. 36-NQ/TW.

To achieve these objectives, the Scheme outlines eight key tasks and solutions, including the intensive research of methodologies and international best practices for assessing the socio-economic impact of biotechnology.